Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$0.53 - $0.93 $1,060 - $1,860
2,000 Added 12.36%
18,180 $10,000
Q4 2023

Jan 23, 2024

BUY
$0.63 - $1.14 $630 - $1,140
1,000 Added 6.59%
16,180 $13,000
Q2 2023

Aug 07, 2023

BUY
$1.31 - $2.04 $2,816 - $4,386
2,150 Added 16.5%
15,180 $24,000
Q2 2022

Aug 11, 2022

BUY
$1.3 - $2.64 $110 - $224
85 Added 0.66%
13,030 $33,000
Q3 2021

Nov 12, 2021

BUY
$4.98 - $6.63 $14,666 - $19,525
2,945 Added 29.45%
12,945 $56,000
Q4 2020

Feb 12, 2021

BUY
$3.17 - $4.49 $31,700 - $44,900
10,000 New
10,000 $32,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Insight Advisors, LLC Portfolio

Follow Insight Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Advisors, LLC with notifications on news.